Moderna says new Covid vaccine was effective against Eris variant in early trial
Publishing timestamp: 2023-08-17 19:50:14
Summary
Moderna's new Covid vaccine has shown a robust immune response against the dominant Eris variant and another rapidly spreading strain of the virus in clinical trials. The updated shot is designed to target the omicron subvariant XBB.1.5. The results suggest that the vaccine may still be effective against newer variants of the virus. Pfizer also announced that their updated Covid shot effectively neutralized XBB.1.5 and Eris in recent trials on mice. Both Moderna's and Pfizer's new vaccines are expected to roll out within weeks pending FDA approval.
Sentiment: POSITIVE
Keywords: business news, biotech and pharmaceuticals, business, biotechnology, covid-19, pfizer inc, coronavirus, breaking news, pharmaceuticals, novavax inc, vaccinations, science, moderna inc, health care industry,
Source: https://www.cnbc.com/2023/08/17/moderna-covid-vaccine-effective-against-eris-fornax-variants.html